Safety, efficacy and acceptability of mifepristone-misoprostol medical abortion in Vietnam

International Family Planning Perspectives, Mar 1999 by Ngoc, Nguyen Thi Nhu, Winikoff, Beverly, Clark, Shelley, Ellertson, Charlotte, Et al

4. He C et al., Study on safety and efficacy of mifepristone plus misoprostol for termination of early pregnancy, Reproduction and Contraception, 1992, 3:1-10; and Winikoff Bet al., Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion, American Journal of Obstetrics and Gynecology, 1997, 176(2):431-437.

5. Winikoff B et al., 1997, op. cit. (see reference 4). 6. Goodkind D, Abortion in Vietnam: measurements, puzzles, and concerns, Studies in Family Planning, 1994,

25(6, part 1):342-352.

7. Johansson A et al., Abortion in context: women's experience in two villages in Thai Birth Province, Vietnam, International Family Planning Perspectives, 1996, 22(3): 103107.

8. Statistical Publishing House, Vietnam Intercensal Demographic Survey, 1994: Major Findings, Hanoi, Vietnam: Statistical Publishing House, 1995.

9. Goodkind D, 1994, op. cit. (see reference 6).

10. Vietnamese Ministry of Health, A strategic assessment of policy, programme and research issues relating to abortion in Vietnam: a draft report, Hanoi, Vietnam, 1997. 11. Winikoff B et al., The acceptability of medical abortion in China, Cuba and India, International Family Planning Perspectives, 1997, 23(2):73-78 & 89; and Winikoff B et al., 1997, op cit. (see reference 4). 12. Winikoff Bet al., Analysis of failure in medical abortion, Contraception, 1996, 54(6):323327. 13. Winikoff Bet al., 1997, op. cit. (see reference 11); and Winikoff B et al., 1997, op. cit. (see reference 4). 14. Winikoff Bet al., 1997, op. cit. (see reference 4); Peyron R et al., 1993, op. cit. (see reference 3); and Aublny E et al., Termination of early pregnancy (up to and after 63 days of amenorrhea) with mifepristone (RU 486) and increasing doses of misoprostol, International Journal of Fertility, 1995, 40(Suppl. 2):85-91.